BackgroundThis study aimed to evaluate the feasibility and efficacy of endovascular treatment for mycotic abdominal aortic aneurysm (AAA) with long‐term follow‐up time period.MethodsPatients with mycotic AAA treated with endovascular aortic repair between January 2009 and December 2017 were included in this study. The preoperative and long‐term outcomes during follow‐up were reviewed and analysed.ResultsSixteen patients (12 males and four females with a mean age of 57.6 ± 14.1 years) were included in this study. The technical success rate was 100%. There were no preoperative mortalities, and one instance of deep venous thrombosis during hospitalization was recorded. The median follow‐up time period was 41.2 (interquartile range 24.8–69.7) months, and the late mortality rate was 12.5%. Three (18.8%) patients presented with reinfection during follow‐up. One patient presented with abdominal abscess and recurrent juxtarenal aortic aneurysm at 40 months post‐operatively, and he received hybrid surgery and abdominal debridement and drainage. One patient developed staphylococcal bloodstream sepsis at 3 months post‐operatively and the other patient developed Salmonella bloodstream sepsis at 9 months post‐operatively. Pathogenic bacteria were consistent with the previous results. They both recovered after 2 months of intravenous antibiotic treatment. At present, all three patients are still alive without endograft infection and receiving outpatient follow‐up. The aneurysm diameter decreased by more than 5 mm among five patients and remained stable in 10 patients at 1 year post‐operatively.ConclusionEndovascular aortic repair is a feasible and effective method of treating mycotic AAA with an acceptable reinfection rate from our single‐centre experience.

This study demonstrated that TEVAR for ATBAD had low perioperative morbidity and mortality and satisfactory midterm outcome. Distal entry tears increase the occurrence of late aortic events and inhibit aortic remolding but do not have a significantly negative effect on late survival. Repairing all entry tears to restore single-lumen blood flow and enhance false lumen thrombosis might benefit selected patients.

This study aims to reveal the experience with endovascular and surgical management of intact splenic artery aneurysms in our single center. MethodBetween January 2011 and June 2017, 42 patients with intact splenic artery aneurysm were enrolled in this study. Twenty patients undergoing surgical intervention were classified as the surgical group, and twenty-two patients who received endovascular repair were categorized as the endovascular group. Demographic data, preoperative comorbidities, and aneurysm anatomical characteristics were collected and analyzed. Details of interventions, perioperative outcomes, and follow-up resultswere evaluated and compared between the two groups. ResultsForty-two patients with a mean age of 53.4±11.6 years were enrolled in this study, and 44 aneurysms were repaired. Thirty-nine (92.9%) patients were asymptomatic, and three (7.1%) patients were symptomatic. The diameter of splenic artery aneurysms was 3.3±1.6 cm, and the shape was mostly saccular. In the surgical group, the common methods used were splenic artery aneurysm resection (nine patients), followed by splenic artery aneurysms resection and splenectomy (six patients), splenic artery aneurysm resection and arterial reconstruction with end-to-end ACCEPTED MANUSCRIPT invasive accompanied with an obvious decrease in surgery time and rapid recovery with a short hospital time.